Cytochrome P450 and arachidonic acid metabolites: Role in myocardial ischemia/reperfusion injury revisited

Cardiovascular Research

Volumn 68, Issue 1, 2005, Pages 18-25

  Gross, Garrett J ^a   Falck, John R ^a   Gross, Eric R ^a   Isbell, Marilyn ^a   Moore, Jeannine ^a   Nithipatikom, Kasem ^a  

^a NONE

Author keywords

Hydroxylase; Arachidonic acid; CYP; Epoxygenase; Infarction; Ischemia; Reperfusion

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 17 OCTADECANOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; ASCORBIC ACID; CHLORAMPHENICOL; CIMETIDINE; CLAMIKALANT; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DAZMEGREL; DIHYDROXYICOSATRIENOIC ACID; EPOXYICOSATRIENOIC ACID; GLIBENCLAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPOXYGENASE; METYRAPONE; MICONAZOLE; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; OPIATE; PHOSPHOLIPASE A2; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; SULFAPHENAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

CARDIOVASCULAR EFFECT; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HYDROXYLATION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULARIZATION;

8,11,14-EICOSATRIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; POTASSIUM CHANNELS; PROSTAGLANDINS; SIGNAL TRANSDUCTION;

EID: 24344464401     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.06.007     Document Type: Review

References (53)

1. S. Wu, W. Chen, E. Murphy, S. Gabel, K.B. Tomer, and J. Foley Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes J Biol Chem 272 1997 12551 12559
2. D.J. Granville, B. Tashakkor, C. Takeuchi, A.B. Gustaafsson, C. Huang, and M.R. Sayen Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors Proc Natl Acad Sci 101 2004 1321 1326
3. K. Nithipatikom, E.R. Gross, M.P. Endsley, J.M. Moore, M.A. Isbell, and J.R. Falck Inhibition of cytochrome P450 ω-hydroxylase: a novel endogenous cardioprotective pathway Circ Res 95 2004 e65 e71
4. + channels and p42/p44 MAPK pathway Circ Res 95 2004 506 514
5. M. Karmazyn Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion Can J Physiol Pharmacol 67 1989 912 921
6. D. Harder, W.B. Campbell, and R.J. Roman Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone J Vasc Res 32 1995 79 92
7. M. Karmazyn The 1990 Merck Frost award. Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions Can J Physiol Pharmacol 69 1991 719 730
8. M. van Bilsen, W. Engels, G.J. van der Vusse, and R.S. Reneman Significance of myocardial eicosanoid production Mol Cell Biochem 88 1989 113 121
9. M.D. Thames, and A.J. Minisi Reflex responses to myocardial ischemia and reperfusion. Role of prostaglandins Circulation 80 1989 1878 1885
10. T. Hohlfeld, H. Strobach, and K. Schror Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury J Pharmacol Exp Ther 264 1993 397 405
11. K. Ichihara, K. Yamamoto, and Y. Abiko Effects of iloprost, a PGI2 derivative on ischemic myocardial energy and carbohydrate metabolism in dogs Mol Cell Biochem 119 1993 133 141
12. N. Ieda, T. Matsubara, and N. Sakamoto Beneficial effects of iloprost on acute myocardial ischemia in dogs Nagoya J Med Sci 57 1994 25 33
13. N. Farber, G.M. Pieper, J.P. Thomas, and G.J. Gross Beneficial effects of iloprost in the stunned canine myocardium Circ Res 62 1988 204 215
14. N.E. Farber, and G.J. Gross Prostaglandin redirection by thromboxane sythetase inhibition. Attenuation of myocardial stunning in canine heart Circulation 81 1990 369 380
15. K. Shinmura, X.L. Tang, Y. Wang, Y.T. Xuan, S.Q. Liu, and H. Takano Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of preconditioning in conscious rabbits Proc Natl Acad Sci 97 2000 10197 10202
16. Y. Guo, W. Bao, W.J. Wu, K. Shinmura, X.L. Tang, and R. Bolli Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice Basic Res Cardiol 95 2000 479 484
17. K. Shinmura, Y.T. Xuan, X.L. Tang, E. Kodani, H. Han, and Y. Zhu Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning Circ Res 90 2002 602 608
18. ATP channel activation Circ Res 84 1999 846 851
19. M.G. Camitta, S.A. Gabel, P. Chulada, J.A. Bradbury, R. Langenbach, and D.C. Zeldin Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning Circulation 104 2001 2453 2458
20. S.A. Gabel, R.E. London, C.D. Funk, C. Steenbergen, and E. Murphy Leukocyte-type 12-lipoxygenase-deficient mice show impaired ischemic preconditioning-induced cardioprotection Am J Physiol (Heart Circ Physiol) 280 2001 H1963 H1969
21. H.H. Patel, R.M. Fryer, A.K. Hsu, M. Isbell, K. Nithipatikom, and R. Jensen Implication of 12-lipoxygenase in opioid-induced delayed cardioprotection by gene array, spectroscopic and pharmacological analyses Circ Res 92 2003 676 682
22. E. Murphy, W. Glasgow, T. Fralix, and C. Steenbergen Role of lipoxygenase metabolites in ischemic preconditioning Circ Res 76 1995 457 467
23. W. Chen, W. Wetsel, C. Steenbergen, and E. Murphy Effect of ischemic preconditioning and PKC activation on acidification during ischemia in the rat heart J Mol Cell Cardiol 28 1996 871 880
24. W. Chen, W. Glasgow, E. Murphy, and C. Steenbergen Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart Am J Physiol (Heart Circ Physiol) 276 1999 H2094 H2101
25. S. Wu, C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 1996 3460 3468
26. S. Wu, W. Chen, E. Murphy, S. Gabel, K.B. Tomer, and C. Steenbergen Molecular cloning, expression and functional significance of a cytochrome P450 highly expressed in rat heart myocytes J Biol Chem 272 1997 12551 12559
27. A. Karara, K. Makita, H.R. Jacobson, J.R. Falck, F.P. Guengrich, and R.N. DuBois Molecular cloning, expression and enzymatic characterization of the rat kidney cytochrome P450 arachidonic acid epoxygenase J Biol Chem 268 1993 13565 13570
28. C.L. Oltman, N.L. Weintraub, M. VanRollins, and K.C. Dellsperger Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation Circ Res 83 1998 932 939
29. W.B. Campbell, D. Gebremedhin, P.F. Pratt, and D.R. Harder Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ Res 78 1996 415 423
30. I. Fleming Cytochrome P450 enzymes in vascular homeostasis Circ Res 89 2001 753 762
31. M. Spieker, and J.K. Liao Vascular protective effects of cytochrome P450 epoxygenase-derived eicosanoids Arch Biochem Biophys 433 2005 413 420
32. M.P. Moffat, C.A. Ward, J.R. Bend, P. Farhangkhoee, and M. Karmazyn Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes Am J Physiol 264 1993 H1154 H1160
33. J. Halpert, B. Naslund, and I. Betner Suicide inactivation of rat liver cytochrome P450 by chloramphenicol in vivo and in vitro Mol Pharmacol 23 1983 445 452
34. R.A. Gottlieb Cytochrome P450: major player in reperfusion injury Arch Biochem Biophys 420 2003 262 267
35. S. Fichtlscherer, S. Dimmeler, S. Breuer, R. Busse, A.M. Zeiher, and I. Fleming Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease Circulation 109 2004 178 183
36. D.L. Kroetz, and F. Xu Regulation and inhibition of arachidonic acid omega-hydroxylase and 20-HETE formation Annu Rev Pharmacol Toxicol 45 2005 413 438
37. M.H. Wang, E. Brand-Sceiber, B.A. Zand, X. Nguyen, J.R. Falck, and N. Balu Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors J Pharmacol Exp Ther 284 1998 966 973
38. E.F. Johnson, D.L. Walker, K.J. Griffin, J.E. Clark, R.T. Okita, and A.S. Meurhoff Cloning and expression of three rabbit kidneys cDNAs encoding lauric acid omega hydroxylases Biochemistry 29 1990 873 879
39. M. Rosolowsky, J.R. Falck, and W.B. Campbell Metabolism of arachidonic acid by canine polymorphonuclear leukocytes: synthesis of lipoxygenase and omega-oxidized metabolites Biochem Biophys Acta 130 1996 143 150
40. Y.H. Ma, D. Gebremedhin, M.L. Schwartzman, J.R. Falck, J.E. Clark, and B.S. Masters 20-hydroxyeicosatetranoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries Circ Res 72 1993 126 136
41. D.R. Harder, D. Gebremedhin, J. Narayanan, C. Jefcoat, J.R. Falck, and W.B. Campbell Formation and action of a P450 4A metabolite of arachidonic acid in cat cerebral microvessels Am J Physiol 266 1994 H2098 H2107
42. J.D. Imig, A.P. Zou, D.E. Stec, D.R. Harder, J.R. Falck, and R.J. Roman Formation and actions of 20-hydroxyeicosatetranoic acid in rat renal arterioles Am J Physiol 270 1996 R217 R227
43. P.F. Pratt, J.R. Falck, K.M. Reddy, J.B. Kurian, and W.B. Campbell 20-HETE relaxes bovine coronary arteries through the release of prostacyclin Hypertension 31 1998 237 241
44. K. Nithipatikom, R.F. DiCamelli, S. Kohler, R.J. Gumina, J.R. Falck, and W.B. Campbell Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs Anal Biochem 292 2001 115 124
45. ATP channel J Mol Cell Cardiol 37 2004 1245 1249
46. + channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes J Physiol 537 3 2001 811 827
47. + channels by epoxyeicosatrienoic acids: a structural determinant study Mol Pharmacol 62 2002 1076 1083
48. P.L. Li, C.L. Chen, R. Bortell, and W.B. Campbell 11,12- epoxyeicosatrienoic acid stimulates endogenous mono-ADP ribosylation in bovine coronary arterial smooth muscle Circ Res 85 1999 349 356
49. A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 2004 55 90
50. B.G. Hoebel, and W.F. Graier 11,12-epoxyeicosatrienoic acid stimulates tyrosine kinase activity in porcine aortic endothelial cells Eur J Pharmacol 346 1998 115 117
51. 5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K Am J Physiol 288 2005 H1955 H1964
52. K. Node, Y. Huo, X. Ruan, B. Yang, M. Spieker, and K. Ley Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1999 1276 1279
53. W.B. Campbell New role for epoxyeicosatrienoic acids as anti-inflammatory mediators Trends Pharmacol Sci 21 2000 125 127